Literature DB >> 343392

Hereditary spherocytosis revisited. Eighth annual Paul M. Aggeler Memorial Lecture. Delivered October 25, 1977, San Francisco General Hospital Medical Center.

W N Valentine.   

Abstract

Entities:  

Mesh:

Year:  1978        PMID: 343392      PMCID: PMC1237962     

Source DB:  PubMed          Journal:  West J Med        ISSN: 0093-0415


× No keyword cloud information.
  50 in total

1.  INCREASED CELL MEMBRANE PERMEABILITY IN THE PATHOGENESIS OF HEREDITARY SPHEROCYTOSIS.

Authors:  H S JACOB; J H JANDL
Journal:  J Clin Invest       Date:  1964-08       Impact factor: 14.808

2.  Hereditary spherocytosis.

Authors:  L E YOUNG
Journal:  Am J Med       Date:  1955-03       Impact factor: 4.965

Review 3.  LEAKY RED CELLS.

Authors:  J H JANDL
Journal:  Blood       Date:  1965-09       Impact factor: 22.113

4.  The structure of fine splenic arterial vessels in relation to hemoconcentration and red cell destruction.

Authors:  L WEISS
Journal:  Am J Anat       Date:  1962-09

5.  Red cell filtration and the pathogenesis of certain hemolytic anemias.

Authors:  J H JANDL; R L SIMMONS; W B CASTLE
Journal:  Blood       Date:  1961-08       Impact factor: 22.113

6.  Alterations in osmotic and mechanical fragility related to in vivo erythrocyte aging and splenic sequestration in hereditary spherocytosis.

Authors:  R C GRIGGS; R WEISMAN; J W HARRIS
Journal:  J Clin Invest       Date:  1960-01       Impact factor: 14.808

7.  Effects of sulfhydryl inhibition on red blood cells. I. Mechanism of hemolysis.

Authors:  H S JACOB; J H JANDL
Journal:  J Clin Invest       Date:  1962-04       Impact factor: 14.808

8.  Sodium transport across the surface membrane of red blood cells in hereditary spherocytosis.

Authors:  J F BERTLES
Journal:  J Clin Invest       Date:  1957-06       Impact factor: 14.808

9.  Relapse in hereditary spherocytosis with proven splenunculus.

Authors:  A E MACKENZIE; D H ELLIOT; H H EASTCOTT; N C HUGHESJONES; P BARKHAN; P L MOLLISON
Journal:  Lancet       Date:  1962-05-26       Impact factor: 79.321

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.